Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.1K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.1K
The pathophysiology of pneumonia involves the following steps:
3.1K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

3.2K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.2K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.4K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.4K
Autoimmune Disorders01:29

Autoimmune Disorders

1.9K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Brain : a journal of neurology·2026
Same author

Four-Specialty Surgical Management of Locally Advanced Inguinal Squamous Cell Carcinoma With Vascular Invasion: A Case Report.

Clinical case reports·2026
Same author

Thymic health under the microscope.

Nature·2026
Same author

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

MEK inhibition prevents human skin graft rejection by promoting CD8<sup>+</sup>TCF1<sup>+</sup> over CD8 effector T cells.

iScience·2025
Same author

Mesenchymal stromal cells conditioned by peripheral blood mononuclear cells exert enhanced immunomodulation capacities and alleviate a model of Myasthenia Gravis.

Stem cell research & therapy·2025

Related Experiment Video

Updated: Feb 15, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.4K

Pathophysiological mechanisms of autoimmunity.

Muriel Sudres1,2,3, Julien Verdier1,2,3, Frédérique Truffault1,2,3

  • 1INSERM U974, Paris, France.

Annals of the New York Academy of Sciences
|January 30, 2018
PubMed
Summary

Autoimmune diseases (AIDs) involve immune system attacks on the body. This review explores similarities between myasthenia gravis (MG) and other AIDs, focusing on immune cell defects and disease chronicity.

Keywords:
Treg cellschronicitygeneticsgerminal centersinflammationtriggering factors

More Related Videos

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

4.6K
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

11.9K

Related Experiment Videos

Last Updated: Feb 15, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.4K
A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

4.6K
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

11.9K

Area of Science:

  • Immunology
  • Genetics
  • Environmental Health

Background:

  • Autoimmune diseases (AIDs) are chronic conditions with self-antigen inflammation, varying in presentation but sharing complex origins.
  • AIDs arise from genetic, epigenetic, and environmental factors causing immune system imbalances.
  • Myasthenia gravis (MG) is an AID involving thymic inflammation and neuromuscular dysfunction, sharing pathogenic mechanisms with other AIDs.

Purpose of the Study:

  • To compare and contrast Myasthenia Gravis (MG) with other autoimmune diseases (AIDs).
  • To review common transcriptome signatures and germinal center development in AIDs.
  • To explore unresolved questions regarding autoimmune mechanisms, regulatory T cell defects, and disease chronicity/specificity.

Main Methods:

  • Comparative review of existing literature on autoimmune diseases and myasthenia gravis.
  • Analysis of common transcriptome signatures across different AIDs.
  • Discussion of germinal center formation and regulatory T cell function in autoimmunity.

Main Results:

  • Identification of shared pathogenic mechanisms and transcriptome signatures between MG and other AIDs.
  • Review of the role of germinal centers in autoimmune responses.
  • Discussion of potential origins for regulatory T cell defects and disease chronicity.

Conclusions:

  • MG shares fundamental autoimmune mechanisms with other AIDs, particularly concerning immune regulation and inflammation.
  • Understanding commonalities like transcriptome signatures and germinal center development offers insights into AID pathogenesis.
  • Further research into regulatory T cell dysfunction and factors driving chronicity is crucial for developing targeted therapies for AIDs.